Bradykinins, Analogs and Sequences

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Online Inquiry

CAT# Product Name M.W Molecular Formula Inquiry
B09001 Lys-[Des-Arg9]-Bradykinin 1032.21 C50H73N13O11 Inquiry
B09002 Bradykinin Potentiator C, Angiotensin I Converting Enzyme Inhibitor 1052.2 Inquiry
B09003 Hemopressin 1054.3 Inquiry
B09005 Bradykinin-Like Neuropeptide (3-11) (Aplysia californica) 1068.21 C42H77N21O12 Inquiry
B09006 (Thr6)-Bradykinin 1074.25 C51H75N15O11 Inquiry
B09007 [Tyr5] Bradykinin 1076.2 C50H73N15O12 Inquiry
B09008 (Tyr8)-Bradykinin 1076.22 C50H73N15O12 Inquiry
B09012 Bradykinin Potentiator B, Angiotensin I Converting Enzyme Inhibitor 1182.3 Inquiry
B09013 [Lys0]-Bradykinin (Kallidin) 1188.4 Inquiry
B09015 Tyr-Bradykinin 1223.40 C59H82N16O13 Inquiry
B09016 [Ile-Ser]-Bradykinin (T-Kinin) 1260.5 Inquiry
B09018 Met-Lys-Bradykinin 1319.60 C61H94N18O13S Inquiry
B09019 Bradykinin-Like Neuropeptide (Aplysia californica) 1327.58 C53H98N24O14S Inquiry
B09024 Bradykinin (2-7) 600.7 C29H40N6O8 Inquiry
B09027 [Leu8, Des-Arg9]-Bradykinin 870 Inquiry
B09030 (1-Adamantanecarbonyl-D-Arg0,Hyp3,beta-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin 1456.76 Inquiry
B09031 (3,4-Dehydro-Pro2·3)-Bradykinin 1056.19 Inquiry
B09033 (D-Arg0,Hyp2·3,D-Phe7)-Bradykinin 1298.47 Inquiry
B09034 (D-Arg0,Hyp3,beta-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin 1294.53 Inquiry
B09035 (D-Arg0,Hyp3,D-Phe7)-Bradykinin 1282.47 Inquiry

Introduction

Bradykinins, analogs, and sequences are a class of a physiological and pharmacologically active peptide containing nine amino acids derived from the kinin group of the protein. The structural order of bradykinin is Arg, Pro, Pro, Gly, Phe, Ser, Pro, Phe, Arg. They are mainly present in tissues and contain less blood, which is formed by high molecular weight kininogens under the action of plasma kallikrein and acts in a paracrine and autocrine manner. They are effectors that promote vasodilation, increased vascular permeability, nitric oxide release, and arachidonic acid flow. They act as important regulators of blood pressure, kidney function, and heart function, and are also involved in the inflammatory response. Bradykinins, analogs, and sequences cause blood vessels to dilate, resulting in a decrease in blood pressure. RMP-7 is a synthetic bradykinin analog. RMP-7 contains three unnatural amino acid substitutions at positions 3, 5, and 8 of bradykinin, and a reducing peptide bond between positions 8 and 9. Because of the specificity of this structure, RMP-7 has higher bradykinin receptor selectivity and longer plasma half-life than bradykinin.

Mechanism of action

The physiological role of bradykinin is mediated by its receptor. The bradykinin receptor is divided into two subtypes, B1 and B2, which are G-protein coupled receptors. The B1 receptor is characterized by low affinity and is not easily saturated. The B1 receptor may be involved in the pathological process of slow pain and inflammation. The B2 receptor is present in many tissues and it mediates most of the response of bradykinin. The B2 receptor has a high affinity, and the bradykinin has the highest affinity for the B2 receptor in the agonist. When bradykinin binds to the B2 receptor, it triggers a series of signaling reactions, including Ca2+ influx, G protein activation, and a series of kinase activation processes.

Application of Bradykinins, analogs and sequences

At present, the use of bradykinin or its analog, such as RMP-7, to selectively open the blood-brain barrier is one of the most effective adjuvant treatments. In countries such as Europe and the United States, the use of bradykinin or its analog RMP-7 to treat brain tumors has entered the stage of clinical trials. Their application is expected to make breakthroughs in the treatment of brain diseases.

Reference

  1. Emerich, D. F., Dean, R. L., Osborn, C., & Bartus, R. T. (2001). The development of the bradykinin agonist Labradimil as a means to increase the permeability of the blood-brain barrier. Clinical pharmacokinetics, 40(2), 105-123.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Obestatin is a 23-amino acid peptide hormone produced in specific epithelial cells of the stomach and small inte ...

 Figure 1. The structural formula of montirelinMontirelin, an analog of thyrotrophin-releasing hormone (TRH) is m ...

 BA 1 (DTyr-Gln-Trp-Ala-Val- Ala-His-Phe-Nle-NH2) is a potent BRS-3 agonist (IC50 = 2.52 nM) and a NMBR and GRPR ...

 Dipeptide diaminobutyroyl benzylamide diacetate, a biologically active polypeptide, classified as a neuropeptide ...

 Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...

Quick Inquiry
×
Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.